SCHEMBL4661689

SCHEMBL4661689

CC(=O)NC(C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24130619 0.81 ALDH1A1 (0.38)
SCHEMBL10861332 0.80 FOLH1 (0.34)
SCHEMBL5157751 0.80 ALDH1A1 (0.39)
SCHEMBL3836275 0.78
SCHEMBL27349597 0.76
SCHEMBL27521998 0.76 ALDH1A1 (0.41)
SCHEMBL4705922 0.76
Hydrochloric Acid SCHEMBL28026139 0.76 CYP2D6 (0.33)
SCHEMBL491239 0.75 TGFBR1 (0.44)
SCHEMBL9702683 0.74 KDM5B (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212339-B1 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS INC (US) 2008-12-31 EP disclosed
EP-1212339-A4 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS INC (US) 2002-09-18 EP disclosed
EP-1212339-A1 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS, INC. (US) 2002-06-12 EP disclosed
WO-2001014400-A1 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS ISIS PHARMACEUTICALS, INC. (US) 2001-03-01 WO disclosed
US-6147200-A NUCLEOSIDES FOR SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES HAVING INCREASED NUCLEASE RESISTANCE AND BETTER BINDING AFFINITY; DIAGNOSIS; ANTISENSE THERAPY ISIS PHARMACEUTICALS, INC. (US) 2000-11-14 US disclosed